|
Feb 12
|
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call
|
|
Dec 31
|
Corcept Submits Application for Another Cushing's Syndrome Drug
|
|
Dec 30
|
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism
|